$38.83
-0.22 (-0.56%)
Open$39.06
Previous Close$39.05
Day High$39.29
Day Low$38.82
52W High$54.85
52W Low$21.12
Volume—
Avg Volume511.0K
Market Cap1.46B
P/E Ratio—
EPS$-0.16
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
-36.5% upside
Current
$38.83
$38.83
Target
$24.64
$24.64
$15.17
$24.64 avg
$37.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 277.67M | 190.98M | 753.50M |
| Net Income | -5,240,347 | -3,243,904 | 117.60M |
| Profit Margin | -1.9% | -1.8% | 15.6% |
| EBITDA | 25.22M | 16.48M | 185.25M |
| Free Cash Flow | — | — | 80.89M |
| Rev Growth | +45.4% | +45.4% | +23.8% |
| Debt/Equity | 4.64 | 4.64 | 0.62 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |